Symptom Burden and Immune Dynamics 6 to 18 Months Following Mild Severe Acute Respiratory Syndrome Coronavirus 2 Infection (SARS-CoV-2): A Case-control Study

Nav

General Info

Geography

Norway (NOR)

Coverage type

Country

Time period covered

01/2020 - 12/2020

Data type

Scientific literature

Keywords

Breathing difficulty, COVID-19, Cognitive impairment, Disease outbreaks, Fatigue, Headache, Long COVID

Citation

Authors

Fjelltveit EB, Blomberg B, Kuwelker K, Zhou F, Onyango TB, Brokstad KA, Elyanow R, Kaplan IM, Tøndel C, Mohn KGI, Özgümüş T, Cox RJ, Langeland N, Bergen COVID-19 Research Group

Journal

Clin Infect Dis

Volume

Issue

Pages

e60-e70

Publication year

2023

Suggested citation

Fjelltveit EB, Blomberg B, Kuwelker K, Zhou F, Onyango TB, Brokstad KA, Elyanow R, Kaplan IM, Tøndel C, Mohn KGI, Özgümüş T, Cox RJ, Langeland N, Bergen COVID-19 Research Group. Symptom Burden and Immune Dynamics 6 to 18 Months Following Mild Severe Acute Respiratory Syndrome Coronavirus 2 Infection (SARS-CoV-2): A Case-control Study. Clin Infect Dis. 2023; 76(3): e60-e70.

DOI

101093cidciac655

PMID

35959897

GHDx Entry last modified on: Mar 22, 2024

Header sites

Search form

Main menu

Symptom Burden and Immune Dynamics 6 to 18 Months Following Mild Severe Acute Respiratory Syndrome Coronavirus 2 Infection (SARS-CoV-2): A Case-control Study

Nav